MJ
Matthew J. Ziegelmann
Biography
Matthew J. Ziegelmann is a professor of urology and a urologist at Mayo Clinic in Rochester, Minnesota.12 He earned his MD at the University of Minnesota Medical School.1 He completed a urology residency at Mayo Clinic and an andrology fellowship with Laurence A. Levine at Rush University.213 He serves on the board of directors of the Sexual Medicine Society of North America.2
Contributions
His cited work covers Peyronie's disease treatment with penile traction, collagenase injections, penile prostheses, and plaque incision with grafting.45678
Cited on WARWIKI
22 publications with Matthew J. Ziegelmann as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.
- Farrell MR, Abdelsayed GA, Ziegelmann MJ, Levine LA. A comparison of hemostatic patches versus pericardium allograft for the treatment of complex Peyronie's disease with penile prosthesis and plaque incision. Urology. 2019;129:113–118. doi
- Ziegelmann M, Savage J, Toussi A, et al. "Outcomes of a novel penile traction device in men with Peyronie's disease: a randomized, single-blind, controlled trial." J Urol. 2019;202(3):599–610. doi
- Toussi A, Ziegelmann M, Yang D, et al. "Efficacy of a novel penile traction device in improving penile length and erectile function post-prostatectomy: results from a single-center randomized, controlled trial." J Urol. 2021;206(2):416–426. doi
- Ziegelmann MJ, Bajic P, Levine LA. "Peyronie's Disease: Contemporary Evaluation and Management." Int J Urol. 2020;27(6):504–516. doi
- Helo S, Bonakdar Hashemi M, Ziegelmann MJ, et al. "Chlorhexidine gluconate application, diabetes, revision surgery, and extended operative time increase risk for penile implant infection." J Sex Med. 2025;22:508–516. doi
- Seyer A, Piraino J, Lozoya AG, Ziegelmann M. "What is the right approach for Peyronie's disease surgery? Comparing postoperative wound complications between ventral and subcoronal incisions with penile straightening surgery." J Sex Med. 2025;22(10):1863–1870. doi
- Chung E, Ziegelmann M, Lin HC, et al. Management of Peyronie's disease: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev. 2026;14:qeaf068. doi
- Ziegelmann M, Hu Y, Xiang Q, et al. Incremental treatment response by cycle with collagenase clostridium histolyticum for Peyronie's disease: a pooled analysis of two phase 3 trials. Urology. 2023;175:126–131. doi
- Joseph J, Ziegelmann MJ, Alom M, et al. "Outcomes of RestoreX penile traction therapy in men with Peyronie's disease: results from open label and follow-up phases." J Sex Med. 2020;17(12):2462–2471. doi
- Ziegelmann MJ, Farrell MR, Levine LA. "Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review." Asian J Androl. 2020;22(1):51–59. doi
- Ziegelmann MJ, Viers BR, Montgomery BD, et al. Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease. Urology. 2017;104:102-109. doi
- Alom M, Burgon H, Ziegelmann M, Köhler T, Helo S, Trost L. "Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie's Disease Men." J Sex Med. 2021;18(6):1092-1098. doiCited on: Peyronie's Disease